A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
Testing Trends-dtet
A Lasting Impact: COVID-19 and Cancer Screening
Several years after the onset of the COVID-19 pandemic, labs are still dealing with the effects of missed and delayed screenings
Lab Data’s New Role as the Backbone of AI-Driven Clinical Trials
Learn how research and development labs can leverage AI to transform laboratory data into actionable insights
Molecular Autopsy Becoming Viable to Implement
...
Already a member? Log in here
Criteria-Based Ordering Improves Vitamin D Testing
...
Already a member? Log in here
Evidence Emerging for More Use Cases for High-Sensitivity Troponin
...
Already a member? Log in here
USPSTF Updates Colorectal Cancer Screening Guidelines to Include Molecular Test
From - Diagnostic Testing & Emerging Technologies
The U.S. Preventive Services Task Force (USPSTF) added molecular colorectal cancer (CRC) screening to its newly updated guidelines, but stopped short of…
Large Panels Complicate Results Reporting for Breast Cancer Risk
...
Already a member? Log in here
Orgs Plan for Personalized Medicine Growth over Next Few Years
From - Diagnostic Testing & Emerging Technologies
Health care experts predict growth and maturation happening in the field of personalized medicine in the next two…
Prospective Trial Shows Utility of Liquid Biopsy for Lung Cancer
...
Already a member? Log in here
Molecular Profiling of Lung Cancer Tumors Feasible on National Scale
From - Diagnostic Testing & Emerging Technologies
Routine, nationwide molecular profiling of patients with advanced non-small cell lung cancer (NSCLC) is feasible and the screening detects actionable alterations that…
